Cyclerion Therapeutics, Inc. (CYCN) scores 60 out of 100 on boothcheck's 11-model valuation framework. Verdict: Hold The estimated fair value is $2.44, representing a 49% margin of safety. Quantitative score: 78/100. Qualitative score: 20/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.